Eli Lilly’s Zepbound outperforms Novo's Wegovy for weight loss in head-to-head trial
Eli Lilly (NYSE:LLY) said Wednesday its weight-loss drug Zepbound (tirzepatide) provided a 47% greater relative weight loss ...
Yahoo Finance12d
Novo Nordisk (NVO) Among the Most Profitable Pharmaceutical Stocks Right Now
In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against the other most profitable pharmaceutical stocks. Healthcare, which includes numerous businesses ...